FDA Remains Cautious as AstraZeneca COVID-19 Vaccine Trial Restarts in the UK
A Phase 3 clinical trial on a COVID-19 vaccine being developed by AstraZeneca in partnership with Oxford University was put on hold after a participant in the United Kingdom (UK)-based study developed severe spinal cord inflammation. The…